Skip to content
Back to meeting Original
Tian Zhang, MD, MHS, FASCO (@tiansterzhangmd.bsky)· @TiansterZhang · X·· 4 days agoScore70

JNJ-6143

Body

@BGarmezy with 1st report of an AR RIPTAC - JNJ-6143 in metastatic castration resistant #prostatecancer showing good PSA responses across aggressive molecular subtypes, median duration 11 months. New mechanism to degrade androgen receptor is active!
@oncoalert #ESMO26 @myESMO

69 views · 7 likes · 6 reposts · 0 replies

Source: Tian Zhang, MD, MHS, FASCO (@tiansterzhangmd.bsky) · x.com

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org

Disclaimer CBA Frontier Insights uses AI-assisted methods to aggregate, summarize, and analyze publicly accessible biopharmaceutical information. Content is provided for informational and educational purposes only and does not represent the official views of original sources or affiliated organizations. AI-generated content may contain errors; please verify important information against primary sources. Intellectual property rights remain with their respective owners. For copyright concerns or corrections, please contact us through the website’s feedback page.